Literature DB >> 29443656

Highlights for Dengue Immunopathogenesis: Antibody-Dependent Enhancement, Cytokine Storm, and Beyond.

Diogo Kuczera1, João Paulo Assolini2, Fernanda Tomiotto-Pellissier2, Wander Rogério Pavanelli2, Guilherme Ferreira Silveira1.   

Abstract

Infection with dengue virus (DENV) can lead to a wide spectrum of clinical presentations, ranging from asymptomatic infection to death. It is estimated that the disease manifests only in 90 million cases out of the total 390 million yearly infections. Even though research has not yet elucidated which are the precise pathophysiological mechanisms that trigger severe forms of dengue, the infection elicits a critical immune response significant for dengue pathogenesis development. Understanding how the immune response to DENV is established and how it can resolve the infection or turn into an immunopathology is of great importance in DENV research. Currently, studies have extensively debated 2 hypotheses involving immune response: antibody-dependent enhancement and cytokine storm. However, despite its undeniable importance in severe forms of the disease, these 2 hypotheses are based on a primed immune status resulting from previous heterologous infection, abstaining them from explaining the severe forms of dengue in naive immune subjects, for example. Thus, it seems that a more intricate arrangement of causes and conditions must be achieved to severe dengue to occur. Among them, the cytokine network signature elicited, in association with viral aspects deserves special attention regarding the establishment of infection and evolution to pathogenesis. In this work, we intend to shed light on how those elements contribute to severe dengue development.

Entities:  

Keywords:  ADE; NS1; cytokine; cytokine storm; dengue; innate immunity

Mesh:

Substances:

Year:  2018        PMID: 29443656     DOI: 10.1089/jir.2017.0037

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  20 in total

Review 1.  Dengue Infection - Recent Advances in Disease Pathogenesis in the Era of COVID-19.

Authors:  Yean Kong Yong; Won Fen Wong; Ramachandran Vignesh; Indranil Chattopadhyay; Vijayakumar Velu; Hong Yien Tan; Ying Zhang; Marie Larsson; Esaki M Shankar
Journal:  Front Immunol       Date:  2022-07-06       Impact factor: 8.786

2.  Zika Virus-Immune Plasmas from Symptomatic and Asymptomatic Individuals Enhance Zika Pathogenesis in Adult and Pregnant Mice.

Authors:  Byoung-Shik Shim; Young-Chan Kwon; Michael J Ricciardi; Mars Stone; Yuka Otsuka; Fatma Berri; Jaclyn M Kwal; Diogo M Magnani; Cody B Jackson; Audrey S Richard; Philip Norris; Michael Busch; Christine L Curry; Michael Farzan; David Watkins; Hyeryun Choe
Journal:  mBio       Date:  2019-07-02       Impact factor: 7.867

3.  Inflammatory status and severity of disease in dengue patients are associated with lipoprotein alterations.

Authors:  Damariz Marin-Palma; Cherilyn M Sirois; Silvio Urcuqui-Inchima; Juan C Hernandez
Journal:  PLoS One       Date:  2019-03-22       Impact factor: 3.240

4.  Primary infection with dengue or Zika virus does not affect the severity of heterologous secondary infection in macaques.

Authors:  Meghan E Breitbach; Christina M Newman; Dawn M Dudley; Laurel M Stewart; Matthew T Aliota; Michelle R Koenig; Phoenix M Shepherd; Keisuke Yamamoto; Chelsea M Crooks; Ginger Young; Matthew R Semler; Andrea M Weiler; Gabrielle L Barry; Holly Heimsath; Emma L Mohr; Jens Eichkoff; Wendy Newton; Eric Peterson; Nancy Schultz-Darken; Sallie R Permar; Hansi Dean; Saverio Capuano; Jorge E Osorio; Thomas C Friedrich; David H O'Connor
Journal:  PLoS Pathog       Date:  2019-08-01       Impact factor: 6.823

5.  T Cell Responses Induced by DNA Vaccines Based on the DENV2 E and NS1 Proteins in Mice: Importance in Protection and Immunodominant Epitope Identification.

Authors:  Paolla B A Pinto; Maysa L Assis; Adriana L Vallochi; Agatha R Pacheco; Lauro M Lima; Kátia R L Quaresma; Bernardo A S Pereira; Simone M Costa; Ada M B Alves
Journal:  Front Immunol       Date:  2019-07-03       Impact factor: 7.561

Review 6.  Susceptibility of the Elderly to SARS-CoV-2 Infection: ACE-2 Overexpression, Shedding, and Antibody-dependent Enhancement (ADE).

Authors:  Jean Pierre Schatzmann Peron; Helder Nakaya
Journal:  Clinics (Sao Paulo)       Date:  2020-05-15       Impact factor: 2.365

Review 7.  Combining Antivirals and Immunomodulators to Fight COVID-19.

Authors:  Vincent Feuillet; Bruno Canard; Alain Trautmann
Journal:  Trends Immunol       Date:  2020-11-13       Impact factor: 16.687

8.  Melatonin Inhibits Dengue Virus Infection via the Sirtuin 1-Mediated Interferon Pathway.

Authors:  Atthapan Morchang; Shilu Malakar; Kanchanaphan Poonudom; Sansanee Noisakran; Pa-Thai Yenchitsomanus; Thawornchai Limjindaporn
Journal:  Viruses       Date:  2021-04-11       Impact factor: 5.048

9.  Maternal Immunity and Vaccination Influence Disease Severity in Progeny in a Novel Mast Cell-Deficient Mouse Model of Severe Dengue.

Authors:  Chinmay Kumar Mantri; Gayathri Soundarajan; Wilfried A A Saron; Abhay P S Rathore; Sylvie Alonso; Ashley L St John
Journal:  Viruses       Date:  2021-05-12       Impact factor: 5.048

Review 10.  I mmunosenescence and Inflammaging: Risk Factors of Severe COVID-19 in Older People.

Authors:  Anna Julia Pietrobon; Franciane Mouradian Emidio Teixeira; Maria Notomi Sato
Journal:  Front Immunol       Date:  2020-10-27       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.